Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

393

LikeLikedUnlike

Episodes 31-45 of 106

Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD
  Peer
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiers
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Advances in MS Management: Current and Future Directions
NeuroFrontiers
Advances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiers
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
- Nancy Kuntz, MD
  Peer
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiers
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
- Nancy Kuntz, MD
  Peer
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
  Peer
- Steven Paul, MD
  Peer
advertisement
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiers
Exploring Metabolomics in Multiple Sclerosis
- Pavan Barghava, MD
  Peer
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiers
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
- Pavan Barghava, MD
  Peer
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple Sclerosis
Strategies and Considerations for Managing MS in Pregnant Women
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Anna A. Shah, MD
  Peer
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple Sclerosis
Managing Multiple Sclerosis: The Impact of Dietary Modifications
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Anna A. Shah, MD
  Peer
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
- Amy Kuceyeski, PhD
  Peer
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiers
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
- Christopher Lock, MD
  Peer
advertisement
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiers
Multiple Sclerosis Explained: Understanding Its Epidemiology
- Jonathan E. Howard, MD
  Peer
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiers
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
- Maxwell H. Levy, MD
  Peer
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
  Peer